These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27586132)

  • 1.
    Rashed HM; Marzook FA; Farag H
    Radiol Med; 2016 Dec; 121(12):935-943. PubMed ID: 27586132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].
    Qi Y; Li G; Chi X; Du L; Huang K; Zhang H; Huang B
    Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):422-6. PubMed ID: 26182867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
    Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
    Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of receptor-based tumor imaging agent: (99m)Tc-folate-glucaric acid.
    Onursal M; Lambrecht FY; Ozgur A
    Int J Pharm; 2011 Sep; 416(1):288-92. PubMed ID: 21782912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radio-labeling of T7 peptide with 99mTc and its biodistribution in nude mice bearing non-small cell lung cancer].
    Hao Y; He X; Zhou X; Meng A; Liu J; Liu J; Song N
    Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):189-96. PubMed ID: 24667254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
    Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD
    Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
    Asikoglu M; Durak FG
    Appl Radiat Isot; 2009 Sep; 67(9):1616-21. PubMed ID: 19457677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M; Shomi S; Iwao H; Ochi H
    Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
    Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
    J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
    Tait JF; Smith C; Blankenberg FG
    J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.
    Kim DW; Kim WH; Kim MH; Kim CG
    Ann Nucl Med; 2015 Nov; 29(9):779-85. PubMed ID: 26179963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, in vitro and in vivo evaluation of (99m)Tc-Annexin B1: a novel radioligand for apoptosis imaging.
    Luo QY; Zhang ZY; Wang F; Lu HK; Guo YZ; Zhu RS
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1102-6. PubMed ID: 16105648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying the biological feasibility of [⁹⁹mTc(CO)₃]-dextran-cysteine-cysteine-mannose as a potential molecular radiopharmaceutical for sentinel node detection.
    Khan IU; Shahid A; Ahmad F; Dar UK; Ahmad M; Javed M
    Ann Nucl Med; 2014 Apr; 28(3):248-56. PubMed ID: 24390658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling of epirubicin with technetium-99m: Optimization, biodistribution and scintigraphic imaging in tumor bearing mice.
    Hina S; Bokhari TH; Roohi S; Rajoka MI; Sohaib M
    Pak J Pharm Sci; 2018 Mar; 31(2):517-524. PubMed ID: 29618443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.
    Yang DJ; Kim CG; Schechter NR; Azhdarinia A; Yu DF; Oh CS; Bryant JL; Won JJ; Kim EE; Podoloff DA
    Radiology; 2003 Feb; 226(2):465-73. PubMed ID: 12563141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [99mTc]demotensin VI: biodistribution and initial clinical results in tumor patients of a pilot/phase I study.
    Gabriel M; Decristoforo C; Wöll E; Eisterer W; Nock B; Maina T; Moncayo R; Virgolini I
    Cancer Biother Radiopharm; 2011 Oct; 26(5):557-63. PubMed ID: 21883013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.